Connable Office’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.18M Sell
29,832
-1,282
-4% -$45.8K 0.1% 88
2026
Q2
$1.05M Sell
31,114
-515
-2% -$17.2K 0.09% 90
2026
Q1
$953K Buy
+31,629
New +$1.02M 0.09% 90
2017
Q1
– Sell
-29,640
Closed -$1.07M – 207
2016
Q4
$1.07M Hold
29,640
– – 0.25% 80
2016
Q3
$1.36M Buy
29,640
+22,230
+300% +$1.16M 0.33% 72
2016
Q2
$372K Buy
7,410
+415
+6% +$22.1K 0.1% 98
2016
Q1
$374K Buy
6,995
+1,235
+21% +$72.5K 0.1% 96
2015
Q4
$378K Sell
5,760
-4,918
-46% -$304K 0.11% 104
2015
Q3
$603K Sell
10,678
-2,568
-19% -$167K 0.18% 79
2015
Q2
$783K Hold
13,246
– – 0.21% 69
2015
Q1
$825K Buy
13,246
+855
+7% +$49.7K 0.21% 69
2014
Q4
$713K Sell
12,391
-107
-0.9% -$5.96K 0.19% 73
2014
Q3
$672K Buy
12,498
+875
+8% +$46.4K 0.18% 75
2014
Q2
$609K Buy
11,623
+7,595
+189% +$388K 0.16% 79
2014
Q1
$213K Buy
+4,028
New +$186K 0.06% 198

Other funds holding TEVA

Connable Office's TEVA Position: Q3 2026 in Review

Connable Office reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 4.1% in Q3 2026, selling an estimated $45.8K and leaving 29,832 shares worth $1.18M. The position accounts for 0.1% of the portfolio, ranked #88.

Connable Office first reported a position in TEVA in Q1 2014 and has held it in 15 quarters since. The position peaked at $1.36M in Q3 2016. 477 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Connable Office held 29,832 shares of Teva Pharmaceutical Industries Limited worth $1.18M as of Q3 2026.
  • Connable Office sold 1,282 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $45.8K.
  • Teva Pharmaceutical Industries Limited made up 0.1% of Connable Office's portfolio in Q3 2026, its #88 holding.
  • Connable Office first reported a position in Teva Pharmaceutical Industries Limited in Q1 2014 and has held it in 15 quarters since.
  • Connable Office's Teva Pharmaceutical Industries Limited position peaked at $1.36M in Q3 2016.
  • 477 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Connable Office's 13F filing for Q3 2026, filed 10 Nov 2026.